Dominic J. Corkill
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, Diabetes Treatment and Management, Asthma and respiratory diseases, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation(2015)262 cited
- → Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor(1997)205 cited
- → Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage(2018)109 cited
- → Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction(2023)96 cited
- → Development of a mouse model mimicking key aspects of a viral asthma exacerbation(2013)42 cited
- → Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly(2017)39 cited
- → Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis(2023)29 cited
- → Neutrophil GM-CSF receptor dynamics in acute lung injury(2019)28 cited
- → Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope “tags”(2014)23 cited
- → The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement(1998)22 cited